Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DANISCO PROBIOTIC
- Development stage
- Unknown
- Lead developer
- International Flavors & Fragrances
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
DANISCO PROBIOTIC is a brand name for a probiotic supplement. One product marketed under this name is manufactured by Vgas Pharmaceutical Joint Stock Company and contains spores of *Bacillus clausii* and *Bacillus subtilis*. [1] It is formulated as an oral liquid and is indicated for the treatment and prevention of intestinal microflora disorders, such as those caused by antibiotic use, leading to symptoms like diarrhea, constipation, and indigestion. [1] It is classified as a functional food or dietary supplement. The developer, Danisco (now part of DuPont Nutrition & Biosciences), has also sponsored clinical research on other probiotic strains for different indications, such as a Phase 2 trial assessing *Lactobacillus paracasei* Lpc-37 (also called Lacticaseibacillus paracasei Lpc-37) for modulating psychological stress. [2, 3, 4, 5]
- Brand names
- DANISCO PROBIOTIC
- Other names
- Lactobacillus paracasei Lpc-37
Beyond the preview
Go deeper on DANISCO PROBIOTIC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DANISCO PROBIOTIC.